Jazz Pharma and Concert ink deal on deuterium-modified sodium oxybate


US drugmakers Jazz Pharmaceuticals (Nasdaq: JAZZ) and Concert Pharmaceuticals have entered into an exclusive…

BiotechnologyConcert PharmaceuticalsJazz PharmaceuticalsLicensingNeurologicalPharmaceuticalResearchsodium oxybateZyrem

Jazz Pharma and Alexza/Valeant get FDA complete response letters, delaying JZP-6 and Staccato, respectively


Two bits of negative news came out of the US Food and Drug Administration that will delay the approvals…

Alexza PharmaceuticalJazz PharmaceuticalsNeurologicalNorth AmericaPharmaceuticalRegulationResearchValeant Pharmaceuticals

US FDA panel says overwhelming “no” to using Jazz Pharma’s date-rape type drug for fibromyalgia


The Joint Advisory Committee of the US Food and Drug Administration, including the Arthritis Advisory…

Jazz PharmaceuticalsNeurologicalNorth AmericaPharmaceuticalRegulationRekinlasodium oxybateXyrem

Back to top